Grant: Discovery Grants Program - Individual
Simon Fraser University
$47,000.00
Imaging eyes: ocular diagnostics by adaptive optics
FY 2022-23
Summary
Recent advancements in ophthalmic imaging have made significant impacts to understanding and treating diseases leading to vision loss. The eye is a uniquely transparent organ, permitting optical imaging of the retina, the light sensitive tissue at the back of the eye. Optical Coherence Tomography (OCT) is a commonly used diagnostic imaging modality that is increasingly being investigated for real-time volumetric imaging. However, even with the good optical performance of the human eye, the lateral resolution of OCT, and related optical imaging techniques, is limited. Adaptive Optics (AO) is needed to obtain the resolution required to visualize the retina at the cellular level. Originally developed for astronomical imaging, AO performs wavefront correction of the light entering the eye using deformable optics, correcting the imperfections in the cornea and intra-ocular lens and permitting diffraction limited focusing on the retina. The purpose of my research program is to investigate novel OCT, AO, and related high resolution imaging technology to overcome the challenges to visualization of the retinal structure and biological function. Short Term Objectives1) Advance real-time OCT with quantitative analysis to guide retinal medical procedures;2) Investigate Wavefront Sensorless Adaptive Optics for cellular resolution retinal imaging in vivo:3) Demonstrate proof of concept experiments for light based retinal therapeutics.SignificanceDiseases affecting vision affect Canada's aging population and amount to billions of dollars in direct costs to the Canadian health care system. The development of novel high resolution diagnostic imaging technology for eye clinics with the potential to detect degenerative changes in the retina earlier and with higher sensitivity is essential to timely vision preserving interventions. Furthermore, the development of high resolution and functional retinal imaging capabilities for preclinical applications has potential to accelerate the development of novel therapies for a broad range of vision robbing and neurological diseases. The technological development has strong potential for generation of novel intellectual property, and for commercialization of novel imaging systems for vision research and vision health care.
Program
Discovery Grants Program - Individual
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2017-05997
Name nom
Sarunic, Marinko
Department département
Engineering Science, School of - Engineering Science, School of
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2017
Award amount
47000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1510
Committee name en
Electrical and Computer Engineering
Committee name fr
Génie électrique et informatique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2500
Research subject group en
Electrical and electronic engineering
Research subject group fr
Génie électrique et électronique
Research subject en
Electrical and electronic engineering
Research subject fr
Génie électrique et électronique
Installment
inst:6
Partie
1
Nb partie
6
Application title
Imaging eyes: ocular diagnostics by adaptive optics
Application summary
Recent advancements in ophthalmic imaging have made significant impacts to understanding and treating diseases leading to vision loss. The eye is a uniquely transparent organ, permitting optical imaging of the retina, the light sensitive tissue at the back of the eye. Optical Coherence Tomography (OCT) is a commonly used diagnostic imaging modality that is increasingly being investigated for real-time volumetric imaging. However, even with the good optical performance of the human eye, the lateral resolution of OCT, and related optical imaging techniques, is limited. Adaptive Optics (AO) is needed to obtain the resolution required to visualize the retina at the cellular level. Originally developed for astronomical imaging, AO performs wavefront correction of the light entering the eye using deformable optics, correcting the imperfections in the cornea and intra-ocular lens and permitting diffraction limited focusing on the retina. The purpose of my research program is to investigate novel OCT, AO, and related high resolution imaging technology to overcome the challenges to visualization of the retinal structure and biological function. Short Term Objectives1) Advance real-time OCT with quantitative analysis to guide retinal medical procedures;2) Investigate Wavefront Sensorless Adaptive Optics for cellular resolution retinal imaging in vivo:3) Demonstrate proof of concept experiments for light based retinal therapeutics.SignificanceDiseases affecting vision affect Canada's aging population and amount to billions of dollars in direct costs to the Canadian health care system. The development of novel high resolution diagnostic imaging technology for eye clinics with the potential to detect degenerative changes in the retina earlier and with higher sensitivity is essential to timely vision preserving interventions. Furthermore, the development of high resolution and functional retinal imaging capabilities for preclinical applications has potential to accelerate the development of novel therapies for a broad range of vision robbing and neurological diseases. The technological development has strong potential for generation of novel intellectual property, and for commercialization of novel imaging systems for vision research and vision health care.